Walvax Biotechnology Co., Ltd. (300142.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 17.45B |
| Enterprise Value | 16.52B |
| P/E Ratio | 90.15 |
| PEG Ratio | 0.75 |
| Price/Sales Ratio | 10.77 |
| Price/Book Ratio | 3.48 |
| Enterprise/Revenue | 10.95 |
| Enterprise/EBITDA | 42.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 2.41B |
| Revenue/Share | 1.5 |
| Gross Profit | 1.66B |
| EBITDA | 577.86M |
| Net Income | 177.74M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 970.1M |
| Total Cash/Share | 0.61 |
| Total Debt | 1.41B |
| Total Debt/Equity | 0.19 |
| Current Ratio | 2.16 |
| Book Value Per Share | 4.89 |
Price History
| 52-Week Change | 22.62 |
| 52-Week High | 16.97 |
| 52-Week Low | 10.88 |
| Moving Average 50 Days | 12.86 |
| Moving Average 200 Days | 12.45 |
Statistics
| Average Volume | 78.55M |
| Shares Outstanding | 1.6B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 0.96 |
| Payout Ratio | 0.18 |
| Last Split Factor | 3:1 |
| Last Split Date | October 14, 2015 |
AD
